AIM: Study of effect of hepatic microsomal enzyme inducers on the Pentobarbital sleeping time in mice.
REFERENCE:
1) Medhi Band Prakash A, Introduction to Experimental Pharmacology, Practical Manual of Experimental and Clinical Pharmacology. Jaypee Brothers Medical Publishers (P) Ltd. First Edition, 2010
2) M.N. Gosh Common Laboratory Animals, Fundamentals of Experimental Pharmacology, Fifth Edition, 2011
3) Kulkarni S.K., Handbook of experimental pharmacology, New Delhi: Vallabh Prakashan, 2014.
INTRODUCTION:
The study investigates how hepatic microsomal enzyme inducers affect Pentobarbital-induced sleep duration in mice. These inducers enhance liver enzyme activity, particularly the cytochrome P450 system, impacting drug metabolism. Hepatic microsomal enzyme inducers activate liver oxidative enzymes, altering drug metabolism. When administered alongside another drug, the duration of action may decrease due to enhanced metabolism. By understanding these interactions, we gain insights into drug efficacy and safety.
REQUIREMENTS:
Animal: Mice(20-25 g)
Apparatus: Mice cages, stopwatch
Drugs: Phenobarbitone sodium (Dose: 50 mg/kg i.p, once a day for 5 days)
Pentobarbital sodium (Dose: 45 mg/kg i.p.)
PRINCIPLE:
Drugs that stimulate the hepatic microsomal oxidative enzyme system augment the metabolism of other medications. The presence of an enzyme inducer will minimize the duration of action of the second medication. This holds considerable clinical significance, since the concurrent administration of multiple drugs may result in one drug altering the effects of another via the induction of microsomal enzymes.
Phenobarbitone and meprobamate are the prevalent medicines that activate the hepatic microsomal enzyme system. The co-administration of any drug with either of these agents may influence the pharmacokinetics of the second drug, hence impacting the intended therapeutic benefits.
PROCEDURE:
1. Weigh and number the animals. Divide them into Two groups, each comprising of at least 6 mice.
2. Prepare a stock solution containing 5 mg/ml of the drug and inject 1 ml/100g of body weight of animal. Prepare fresh solution everyday
3. To the First group inject Phenobarbitone once daily for 5 days. To second group inject distilled water, similarly for 5 days.
4. Prepare a stock solution containing 4.5 mg/ml of the drug and inject 1 ml/100g of the body weight of animal.
5. One hour after the last dose of phenobarbitone on the 5th day, inject pentobarbital to both the groups.
6. Note the onset and duration of sleep due to pentobarbital in both the groups.
OBSERVATION TABLE:
Sr no.
Body wt. (gm)
Treatment
Onset of action(min.)
Duration of action (min.)
% reduction in sleep time
Group 1 (Pentobarbital Treated group)
1
2
3
4
5
6
Mean
Group 2 (Phenobarbitone + Pentobarbital treated group)
INFERENCE:
20
Distilled water for 5 days followed by Pentobarbital
(45mg/kg i.p on 5th day)
10
25
37.5
22
12
23
9
28
24
8
26
21
9.5
25.33
Phenobarbitone 50mg/kg i.p for 5 days followed by Pentobarbital
15
17
16
11
9.33
15.83
*Observation table after completion of the experiment can be downloaded by clicking tab (RJPT SimLab)
DISCLAIMER: "The results provided here are only for reference or comparison purposes. Students are expected to perform the experiment and record their actual observations."
GRAPH:
RESULT:
The average sleeping time in the control group (Group 1), which received only pentobarbital after 5 days of distilled water, was 25.33 minutes. In contrast, the experimental group (Group 2), which was pretreated with phenobarbitone (a hepatic microsomal enzyme inducer), showed a significantly reduced average sleeping time of 15.83 minutes. This indicates a ~37.5% reduction in sleeping time due to prior administration of the enzyme inducer. The decreased duration of pentobarbital-induced sleep in Group 2 suggests enhanced hepatic metabolism of pentobarbital owing to induction of liver microsomal enzymes by phenobarbitone.
Download User Manual: Click to Download
